VEGFB is implicated in angiogenesis and tumor progression (Hicklin and Ellis, 2005) and IL33 is a prognostic marker of cancer progression and angiogenesis (Choi et al., 2009; Cui et al., 2018; Shen, Liu and Zhang, 2018). Here, IL33 is linked to cancer.